Professional Role and Scope at Merck & Co.
Carmen Villar currently serves as Vice President of Social Business Innovation at Merck & Co., a leading pharmaceutical company headquartered in Kenilworth, New Jersey. In this senior executive role, she oversees critical social impact initiatives, including direct leadership of the Merck Foundation, the Merck Office of Corporate Responsibility, and the company's broader corporate social innovation portfolio. Her position integrates social business strategies with corporate responsibility efforts to advance health equity, disease prevention, and sustainable community impact associated with Merck’s global operations.
She publicly articulated Merck's commitment to environmental, social, and governance (ESG) principles, describing ESG as “in our DNA as a company” (FiercePharma, Oct 2022). Under her leadership, Merck has been recognized as the No.1 pharmaceutical industry company among Barron’s 100 Most Sustainable US Companies (2023), highlighting the effectiveness and public visibility of the company’s social business initiatives.
Career Background and Expertise
Carmen Villar possesses over 25 years of combined government and corporate experience in global public health and social innovation. Before joining Merck in 2017, she held various roles for more than 20 years at the U.S. Centers for Disease Control and Prevention (CDC), culminating as Chief of Staff to the CDC Director. During her CDC tenure, she managed major public health emergency responses, including:
- The West African Ebola epidemic
- The Zika virus outbreak
Prior to becoming Chief of Staff, she provided leadership and operational oversight for CDC programs in Nigeria and Zambia, enhancing international public health collaborations. Her CDC roles spanned work on HIV policy, breast and cervical cancer control programs, and a deep focus on public health equity.
Her transition to Merck shifted her focus from public sector disease control and health emergency management to corporate-driven health equity and social business innovation, strategically integrating social objectives into business models and philanthropy.
Education and Skills
- Bachelor’s degree in Anthropology with a minor in Ethnic Studies from the University of California, Berkeley.
- Master’s degree in Social Welfare, concentrating on health settings, also from UC Berkeley.
- Fluent in Spanish.
- Strong grounding in cultural anthropology and its application to public health programs, offering a nuanced understanding of community-based health interventions and policy development.
Board Memberships and External Leadership Roles
Carmen Villar has served on the National Medical Fellowships (NMF) Board of Directors as vice president of social business innovation for more than six years, leveraging her expertise to support the next generation of diverse medical professionals.
She was elected as co-chair of the New Jersey Performing Arts Center (NJPAC) Board in 2023, a role recognizing her commitment to community impact beyond the pharmaceutical and health sectors. This appointment also reflects her leadership influence within New Jersey’s civic and social infrastructure.
Key Initiatives and Public Recognition
- Merck Foundation’s $20 million initiative aimed at advancing equity in U.S. cancer care (2022), reflecting her leadership in addressing disparities in oncology treatment access.
- Prominent spokesperson and advocate for health equity, access, diversity, and sustainable ESG frameworks within Merck and across the pharmaceutical industry.
- Publicly acknowledged for advancing Merck’s impact investment strategies and social business innovation models aligned with corporate citizenship and environmental stewardship.
Notable Media and Thought Leadership
- Featured in interviews and articles by entities including NationSwell, FiercePharma, and Stage 4 Solutions, emphasizing her career path, social innovation expertise, and perspectives on strategic public health decision-making.
- Participated in CEO-level discussions centered on scientific innovation amplification and health equity integration within corporate frameworks.
- Her career narrative emphasizes the importance of ground-level health program experience, underpinning her strategic approach to social business innovation.
This profile positions Carmen Villar as a seasoned executive with a robust background in public health leadership and social innovation in the pharmaceutical sector. Her expertise in integrating social impact with corporate strategy, combined with her extensive government and international health experience, underscores her influential role in advancing Merck’s societal mission and sustainability agenda.
